Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology | Pediatrics/Neonatology | Neurology | Family Medicine
Obsessive-Compulsive Disorder Clinical Trials
A listing of Obsessive-Compulsive Disorder medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Alabama
Harmonex Neuroscience Research
Dothan Alabama 36303
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
California
UCLA Semel institute
Los Angeles California 90024
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Oceanside California 92056
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Stanford California 94305-2200
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Connecticut
Institute of Living/Hartford Hospital
Hartford Connecticut 06106
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
New Haven Connecticut 06519
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Florida
University of Florida
Gainesville Florida 32610
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Medical Research Group of Central Florida
Orange City Florida 32763
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Harmonex Neuroscience of Pensacola
Pensacola Florida 32502
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
University of South Florida - Rothman Center
St. Petersburg Florida 33701
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
View More »
St. Petersburg Florida 33701
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Tampa Florida 33613
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Illinois
Family Behavioral Health
Plainfield Illinois 60585
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Kansas
Family Service and Guidance Center
Topeka Kansas 66606
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Massachusetts
Massachusetts General Hospital
Boston Massachusetts 02114
A clinical research study of Duloxetine for the treatment of Obsessive Compulsive Disorder
Massachusetts General Hospital
Boston Massachusetts 02114
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Boston Massachusetts 02114
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Minnesota
Minneapolis Minnesota 55454
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Mayo Clinic
Rochester Minnesota 55905
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Missouri
Saint John's Clinic
Springfield Missouri 65804
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
St. Louis Missouri 63118
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
New York
Mount Sinai School of Medicine
New York New York 10029
A clinical trial to evaluate treatments using topiramate for patients with Obsessive-Compulsive Disorder
New York New York 10029
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
North Carolina
3-C Family Services, P.A.
Cary North Carolina 27513
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Private Practice
Wilmington North Carolina 28401
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Ohio
Family Center by the Falls
Chagrin Falls Ohio 44023
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Cincinnati Childrens Hospital and Medical Center
Cincinnati Ohio 45220
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
W.O. Walker Building
Cleveland Ohio 44106
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Pennsylvania
View More »
Child Guidance Resource Center
Havertown Pennsylvania 19083
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Norristown Pennsylvania 19403
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Rhode Island
Providence Rhode Island 02906
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Tennessee
Memphis Tennessee 38119
Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder
Texas
Bay Pointe Behavioral Health Service, Inc.
Friendswood Texas 77546
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Midtown Psychiatry and TMS Center
Houston Texas 77007
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Virginia
University of Virginia Health System
Charlottesville Virginia 22903
A Phase 4 clinical study for patients with Obsessive Compulsive Disorder
Canada
MacAnxiety Research Centre
Hamilton Ontario L8S 1B7
A clinical research study of pregabalin and Placebo for the treatment of Obsessive-Compulsive Disorder
MacAnxiety Research Centre
Hamilton Ontario L8S 1B7
A Phase 4 clinical study for patients using Sertraline and Placebo
MacAnxiety Research Centre
Hamilton Ontario L8S 1B7
Patients are needed to participate in a clinical research study of Topiramate and placebo to evaluate Obsessive Compulsive Disorder
University of Ottawa Institute of Mental Health Research
Ottawa Ontario K1Z7K4
Patients are needed to participate in a clinical research study of Escitalopram to evaluate Obsessive Compulsive Disorder
Israel
Sheba Medical Center
Ramat Gan
Patients are needed to participate in a clinical research study evaluating Deep TMS for the treatment of Obsessive Compulsive Disorder
Department of Psychiatry Chaim Sheba Medical Center
Tel Hashomer
A clinical trial to evaluate treatments using Agomelatine A and Placebo for patients with Obsessive Compulsive Disorder
Japan
Site Reference ID/Investigator# 105820
Hokkaido
A clinical research study of fluvoxamine maleate and placebo for the treatment of Obsessive Compulsive Disorder
Site Reference ID/Investigator# 105818
Hyogo
A clinical research study of fluvoxamine maleate and placebo for the treatment of Obsessive Compulsive Disorder
Site Reference ID/Investigator# 105816
Moriguchi
A clinical research study of fluvoxamine maleate and placebo for the treatment of Obsessive Compulsive Disorder